株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ゲノミクスの世界市場 - 2024年までの予測:シークエンシング・マイクロアレイ・PCR (ポリメラーゼ連鎖反応)

Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024

発行 MarketsandMarkets 商品コード 294503
出版日 ページ情報 英文 195 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.25円で換算しております。
Back to Top
ゲノミクスの世界市場 - 2024年までの予測:シークエンシング・マイクロアレイ・PCR (ポリメラーゼ連鎖反応) Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024
出版日: 2019年03月07日 ページ情報: 英文 195 Pages
概要

世界のゲノミクス市場は、2019年の189億米ドルから2024年までに357億米ドルへ達すると予測され、この間は13.5%のCAGR (年間複合成長率) が予測されています。政府資金の増加およびゲノミクスプロジェクト数の増加、シークエンシングコストの減少、ゲノミクスの応用領域の拡大、および新興企業のゲノミクス領域への参入といった要因がゲノミクス市場の成長を促進しています。しかし、ゲノミクス装置の高コスト性は、同市場の成長を抑制する主な要因のひとつとなっています。

当レポートでは、世界のゲノミクス市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

4.1 GENOMICS: MARKET OVERVIEW
FIGURE 13 RISING GOVERNMENT FUNDING AND GROWTH IN THE NUMBER OF GENOMICS PROJECTS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • ゲノミクス:市場概要
  • 北米のゲノミクス市場:技術別
  • アジア太平洋のゲノミクス市場:製品・サービス別
  • ゲノミクス市場の地域概要

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 ゲノミクス市場:製品・サービス別

  • イントロダクション
  • 消耗品
  • システム & ソフトウェア
  • サービス

第7章 ゲノミクス市場:技術別

  • イントロダクション
  • PCR (ポリメラーゼ連鎖反応)
  • シークエンシング
  • マイクロアレイ
  • 核酸抽出・精製
  • その他の技術

第8章 ゲノミクス市場:用途別

  • イントロダクション
  • 診断
  • 創薬・新薬の開発
  • 精密医療
  • 農業・動物研究
  • その他

第9章 ゲノミクス市場:エンドユーザー別

  • イントロダクション
  • 研究センター、学術機関、政府機関
  • 病院・診療所
  • 製薬・バイオテクノロジー企業
  • その他

第10章 ゲノミクス市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他

第11章 競合情勢

  • 概要
  • 競合状況
  • 競合リーダーシップマッピング
  • 競合ベンチマーキング
  • 競合リーダーシップマッピング (新興企業)

第12章 企業プロファイル

  • ILLUMINA
  • THERMO FISHER SCIENTIFIC
  • QIAGEN
  • EUROFINS SCIENTIFIC
  • AGILENT TECHNOLOGIES
  • OXFORD NANOPORE TECHNOLOGIES
  • F. HOFFMANN-LA ROCHE
  • BIO-RAD LABORATORIES
  • BGI
  • DANAHER
  • GE HEALTHCARE
  • EPPENDORF

第13章 付録

図表

LIST OF TABLES

  • TABLE 1: GENOMICS MARKET, BY PRODUCT AND SERVICE, 2017-2024 (USD MILLION)
  • TABLE 2: GENOMICS MARKET FOR CONSUMABLES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 3: GENOMICS MARKET FOR SYSTEMS/SOFTWARE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 4: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 5: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 6: GENOMICS MARKET FOR PCR, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 7: GENOMICS MARKET FOR SEQUENCING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8: GENOMICS MARKET FOR MICROARRAY, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 9: GENOMICS MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 10: GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 11: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 12: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 14: GENOMICS MARKET FOR PRECISION MEDICINE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 18: GENOMICS MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 19: GENOMICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 20: GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22: GENOMICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 24: NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 25: NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 27: NORTH AMERICA: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 28: US: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 29: US: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 30: US: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 31: US: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 32: INDICATIVE LIST OF PROJECTS FUNDED BY GAPP IN 2018
  • TABLE 33: CANADA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 34: CANADA: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 35: 0CANADA: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 36: CANADA: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 37: EUROPE: GENOMICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 39: EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 40: EUROPE: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 41: EUROPE: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 42: UK: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 43: UK: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 44: UK: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 45: UK: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 46: GERMANY: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 47: GERMANY: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 48: GERMANY: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 49: GERMANY: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 50: FRANCE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 51: FRANCE: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 52: FRANCE : GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 53: FRANCE: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 54: ROE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 55: ROE: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 56: ROE: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 57: ROE: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 58: ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 59: ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 60: ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 63: CHINA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 64: CHINA: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 65: CHINA: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 66: CHINA: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 67: INDIA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 68: INDIA: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 69: INDIA: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 70: INDIA: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 71: JAPAN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 72: JAPAN: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 73: JAPAN: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 74: JAPAN: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 75: ROAPAC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 76: ROAPAC: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 77: ROAPAC: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 78: ROAPAC: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 79: ROW: GENOMICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 80: ROW: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 81: ROW: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 82: ROW: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 83: ROW: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 84: MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 85: MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 86: MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 87: MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 88: LATIN AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 89: LATIN AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 90: LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 91: LATIN AMERICA: GENOMICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 92: PRODUCT LAUNCHES AND APPROVALS
  • TABLE 93: EXPANSIONS
  • TABLE 94: AGREEMENTS AND COLLABORATIONS
  • TABLE 95: ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1: GENOMICS MARKET SEGMENTATION
  • FIGURE 2: GENOMICS MARKET: RESEARCH METHODOLOGY
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018
  • FIGURE 9: GENOMICS MARKET, BY TECHNOLOGY, 2018
  • FIGURE 10: GENOMICS MARKET, BY APPLICATION, 2018
  • FIGURE 11: GENOMICS MARKET, BY END USER, 2018
  • FIGURE 12: GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET
  • FIGURE 13: RISING GOVERNMENT FUNDING AND GROWTH IN THE NUMBER OF GENOMICS PROJECTS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14: PCR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN GENOMICS MARKET IN 2018
  • FIGURE 15: CONSUMABLES SEGMENT COMMANDED THE LARGEST SHARE OF THE ASIA PACIFIC GENOMICS MARKET IN 2018
  • FIGURE 16: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE GENOMICS MARKET IN 2019
  • FIGURE 18: PCR SEGMENT WILL CONTINUE TO DOMINATE THE GENOMICS MARKET IN THE FORECAST PERIOD
  • FIGURE 19: DIAGNOSTIC APPLICATIONS TO DOMINATE THE GENOMICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES TO COMMAND THE LARGEST SHARE OF THE GENOMICS MARKET IN 2019
  • FIGURE 21: NORTH AMERICA WILL CONTINUE TO DOMINATE THE GENOMICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: NORTH AMERICA: GENOMICS MARKET SNAPSHOT
  • FIGURE 23: EUROPE: GENOMICS MARKET SNAPSHOT
  • FIGURE 24: ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
  • FIGURE 25: ROW: GENOMICS MARKET SNAPSHOT
  • FIGURE 26: GENOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 27: COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET
  • FIGURE 28: COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET
  • FIGURE 29: ILLUMINA, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 30: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 31: QIAGEN N.V.: COMPANY SNAPSHOT (2017)
  • FIGURE 32: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 33: AGILENT TECHNOLOGIES : COMPANY SNAPSHOT (2017)
  • FIGURE 34: ROCHE HOLDING AG: COMPANY SNAPSHOT (2017)
  • FIGURE 35: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 36: DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 37: GENERAL ELECTRICAL COMPANY: COMPANY SNAPSHOT (2017)
  • FIGURE 38: EPPENDORF AG: COMPANY SNAPSHOT (2017)
目次
Product Code: BT 2209

"Genomics market is projected to grow at a CAGR of 13.5% during the forecast period"

The global genomics market is projected to reach USD 35.7 billion by 2024 from USD 18.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Factors such as the rising government funding and growth in the number of genomics projects, decreasing sequencing costs, growing application areas of genomics, and the entry of new players and start-ups in the genomics field are driving the growth of the genomics market. However, the high cost of genomic equipment is one of the major factors restraining the growth of this market.

"The services segment is projected to grow at the highest CAGR during the forecast period"

Based on product & service, the genomics market is segmented into consumables, systems & software, and services. During the forecast period, the services segment is expected to grow at the highest CAGR majorly due to the increasing awareness of genomics and the reducing cost of DNA sequencing.

"Diagnostic applications to grow at the highest CAGR during the forecast period"

Based on application, the genomics market is segmented into diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and other applications. During the forecast period, the diagnostic applications segment is projected to grow at the highest CAGR majorly due to the increasing awareness of genomics among patients and the improving efficiency of genomic sequencing in the diagnosis of diseases.

"In the end-user market, the hospitals and clinics segment is estimated to witness the highest growth during the forecast period"

Based on end user, the genomics market is segmented into research centers and academic & government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users. During the forecast period, the hospitals and clinics segment is estimated to grow at the highest CAGR owing to the growing availability of genetic tests and pharmacogenomics and the rising emphasis on providing personalized medicine in hospitals.

"Growing investments and favorable government initiatives for genomics research to offer growth opportunities in North America during the forecast period"

During the forecast period, the North American market is estimated to witness high growth owing to factors such as the implementation of favorable initiatives by governments in the US and Canada and rising investments in the pharmaceutical, biotechnology, medical, and academic research sectors in these countries.

Breakdown of supply-side primary interviews:

  • By Company Type - Tier I: 55%, Tier II: 25%, and Tier III: 20%
  • By Designation - C-level: 43%, Director-level: 32%, and Others: 25%
  • By Region - North America: 38%, Europe: 23%, Asia Pacific: 29%, and RoW: 10%

QIAGEN (Netherlands), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Agilent Technologies (US), Illumina (US), Pacific Biosciences of California (US), Eurofins Scientific (Germany), BGI (China), GE Healthcare (UK), F. Hoffmann-La Roche (Switzerland), Oxford Nanopore Technologies (UK), and Eppendorf (Germany) are the major players operating in this market.

Research Coverage:

This report studies the genomics market based on product and service, application, end user, and region. It also includes an analysis of factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, the market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the genomics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GENOMICS: MARKET OVERVIEW
  • 4.2. NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2018
  • 4.3. ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising government funding and growth in the number of genomics projects
      • 5.2.1.2. Decreasing sequencing costs
      • 5.2.1.3. Growing application areas of genomics
      • 5.2.1.4. Entry of new players and start-ups in the genomics market
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of genomic equipment
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Use of genomics in specialized/personalized medicine
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Dearth of trained professionals
      • 5.2.4.2. Secure storage of large volumes of sequenced data

6. GENOMICS MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
    • 6.2.1. CONSUMABLES FORMS THE LARGEST SEGMENT OF THE GENOMICS MARKET
  • 6.3. SYSTEMS & SOFTWARE
    • 6.3.1. WITH GENOME SEQUENCING AVAILABLE AT SUBSTANTIALLY LOWER RATES, THE DEMAND FOR SYSTEMS & SOFTWARE IS EXPECTED TO INCREASE
  • 6.4. SERVICES
    • 6.4.1. THE SERVICES SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

7. GENOMICS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. PCR
    • 7.2.1. PCR ALLOWS RESEARCHERS TO PRODUCE MILLIONS OF COPIES OF A SPECIFIC DNA SEQUENCE WITHIN HOURS
  • 7.3. SEQUENCING
    • 7.3.1. INCREASING APPLICATIONS OF SEQUENCING IN ANIMAL BREEDING, AGRICULTURE, AND HUMAN GENOMICS TO DRIVE MARKET GROWTH
  • 7.4. MICROARRAY
    • 7.4.1. MICROARRAY TECHNOLOGIES ARE WIDELY USED IN THE FIELD OF GENOMICS DUE TO THEIR LOW COST
  • 7.5. NUCLEIC ACID EXTRACTION AND PURIFICATION
    • 7.5.1. ADVANCES IN NUCLEIC ACID EXTRACTION AND PURIFICATION TECHNOLOGIES ARE EXPECTED TO SUPPORT THE GROWTH OF THIS MARKET
  • 7.6. OTHER TECHNOLOGIES

8. GENOMICS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. DIAGNOSTICS
    • 8.2.1. DIAGNOSTICS FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE GENOMICS MARKET
  • 8.3. DRUG DISCOVERY AND DEVELOPMENT
    • 8.3.1. GROWING APPLICATION OF GENOMICS IN THE AREA OF DRUG DISCOVERY AND DEVELOPMENT TO PROPEL MARKET GROWTH
  • 8.4. PRECISION MEDICINE
    • 8.4.1. PRECISION MEDICINE FOCUSES ON IDENTIFYING THE MOST EFFECTIVE MEDICAL TREATMENTS FOR PATIENTS BASED ON THEIR GENETIC, ENVIRONMENTAL, AND LIFESTYLE FACTORS
  • 8.5. AGRICULTURE & ANIMAL RESEARCH
    • 8.5.1. GENOMICS HELPS IN IMPROVING THE PRODUCTIVITY OF CROPS AND LIVESTOCK
  • 8.6. OTHER APPLICATIONS

9. GENOMICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
    • 9.2.1. INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF GENOMICS SYSTEMS AMONG ACADEMIC & GOVERNMENT INSTITUTES
  • 9.3. HOSPITALS & CLINICS
    • 9.3.1. INCREASING DEMAND FOR PHARMACOGENOMICS TO DRIVE THE ACCEPTANCE OF NGS IN HOSPITALS
  • 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.4.1. GROWING IMPORTANCE OF BIOMARKERS TO DRIVE THE USE OF GENOMIC SYSTEMS AND SERVICES AMONG PHARMA & BIOTECH COMPANIES
  • 9.5. OTHER END USERS

10. GENOMICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
      • 10.2.1.1. US dominates the North American genomics market due to the increasing research funding and government initiatives for promoting precision medicine and the use of GM crops
    • 10.2.2. CANADA
      • 10.2.2.1. Increasing research in the field of genomics to drive market growth
  • 10.3. EUROPE
    • 10.3.1. UK
      • 10.3.1.1. UK to register the highest CAGR in the European genomics market during the forecast period
    • 10.3.2. GERMANY
      • 10.3.2.1. Availability of funding for life sciences research to boost market growth in Germany
    • 10.3.3. FRANCE
      • 10.3.3.1. Increasing government investments in genomics to boost the growth of the French genomics market
    • 10.3.4. ROE
  • 10.4. ASIA PACIFIC
    • 10.4.1. CHINA
      • 10.4.1.1. China is expected to command the largest share of the Asia Pacific market
    • 10.4.2. INDIA
      • 10.4.2.1. Emergence of local players is expected to aid the growth of the genomics market in India
    • 10.4.3. JAPAN
      • 10.4.3.1. Increasing government focus on cancer research in Japan to increase demand for genomics products
    • 10.4.4. REST OF ASIA PACIFIC
  • 10.5. REST OF THE WORLD
    • 10.5.1. MIDDLE EAST AND AFRICA
      • 10.5.1.1. Increasing adoption of genetic testing in the Middle East and rising HIV & cancer incidence in Africa are driving market growth
    • 10.5.2. LATIN AMERICA
      • 10.5.2.1. Government funding and partnerships to boost the adoption of genomics products and services in Latin America

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
    • 11.1.1. THERMO FISHER SCIENTIFIC
    • 11.1.2. ILLUMINA
    • 11.1.3. QIAGEN
    • 11.1.4. OTHERS
  • 11.2. COMPETITIVE SCENARIO
    • 11.2.1. PRODUCT LAUNCHES AND APPROVALS
    • 11.2.2. EXPANSIONS
    • 11.2.3. AGREEMENTS AND COLLABORATIONS
    • 11.2.4. ACQUISITIONS
  • 11.3. COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2018)
    • 11.3.1. VISIONARY LEADERS
    • 11.3.2. INNOVATORS
    • 11.3.3. DYNAMIC DIFFERENTIATORS
    • 11.3.4. EMERGING COMPANIES
  • 11.4. COMPETITIVE BENCHMARKING
    • 11.4.1. ANALYSIS OF THE PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE GENOMICS MARKET (25 COMPANIES)
    • 11.4.2. BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE GENOMICS MARKET (25 COMPANIES)
  • 11.5. COMPETITIVE LEADERSHIP MAPPING (START-UP) (2018)
    • 11.5.1. PROGRESSIVE COMPANIES
    • 11.5.2. STARTING BLOCKS
    • 11.5.3. DYNAMIC COMPANIES
    • 11.5.4. RESPONSIVE COMPANIES

12. COMPANY PROFILES (Business Overview, Products Offered, Service Offered Recent Developments, MnM View)*

  • 12.1. ILLUMINA, INC.
  • 12.2. THERMO FISHER SCIENTIFIC
  • 12.3. QIAGEN
  • 12.4. EUROFINS SCIENTIFIC
  • 12.5. AGILENT TECHNOLOGIES
  • 12.6. OXFORD NANOPORE TECHNOLOGIES
  • 12.7. F. HOFFMANN-LA ROCHE
  • 12.8. BIO-RAD LABORATORIES
  • 12.9. BGI
  • 12.10. DANAHER CORPORATION
  • 12.11. GE HEALTHCARE
  • 12.12. EPPENDORF

*Business Overview, Products Offered, Service Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. AVAILABLE CUSTOMIZATIONS
  • 13.4. RELATED REPORTS
  • 13.5. AUTHOR DETAILS
Back to Top